Altre lingue Illumina, Inc.

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 24/05/2024			Variaz. 5gg	Var. 1 gen.
106,5 ^USD	+0,60%		-4,13%	-23,53%

15/05	ILLUMINA, INC. : Daiwa Securities conferma il giudizio Neutral	ZM
14/05	Transcript : Illumina, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 08:30 AM

Anna Richo joins Illumina's Board of Directors	20/05
Illumina To Webcast Upcoming Investor Conference	15/05
Devyser Diagnostics AB publishes quarterly report for the period January to March 2024	08/05
Illumina Files Registration Statement for Planned GRAIL Divestiture	07/05
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL	07/05
Illumina to Webcast Upcoming Investor Conference	06/05
Illumina To Webcast Upcoming Investor Conference	03/05
EE.UU. - Valores a seguir en Wall Street (actualizado)	03/05
Illumina : First Quarter 2024 Prepared Remarks	03/05
Illumina reaffirms annual revenue forecast over continued sluggish demand	03/05
Illumina Q1 Non-GAAP Earnings Increase, Revenue Decreases -- Shares Down After Hours	02/05
Illumina: Q1 Earnings Snapshot	02/05
Earnings Flash (ILMN) ILLUMINA Posts Q1 EPS $0.09, vs. Street Est of $0.10	02/05
Earnings Flash (ILMN) ILLUMINA Posts Q1 Revenue $1.08B, vs. Street Est of $1.05B	02/05
Illumina, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2024	02/05
Illumina, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Illumina : 2024 Assurance Statement	23/04
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16/04
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16/04
Illumina's planned divestment of GRAIL approved by the European Commission	15/04

Non ci sono risultati per questa ricerca